ONAKTA (Seqirus Pty Ltd)
Product name
ONAKTA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
229 (255 working days)
Active ingredients
tirbanibulin
Registration type
NCE/NBE
Indication
ONAKTA® is indicated for the topical field treatment of non-hyperkeratotic, nonhypertrophic actinic keratosis of the face or scalp in adults.